For research use only
| Cat No. | ABC-X0268C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human FLT3 (N701K) BAF3 Cell Line is highly valuable for investigating FLT3 mutation impact on leukemia cell growth and treatment resistance mechanisms.
Human FLT3 (N701K) BAF3 Cell Line is a genetically engineered BAF3 model expressing FLT3 with the N701K mutation, established via lentiviral transduction. Cells are expanded at low passage (<P20) and validated by qRT-PCR. Target FLT3 N701K confers resistance to type I FLT3 inhibitors and is emerging as a clinically relevant secondary mutation in AML patients under targeted therapy. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0268C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Application